Electrophoresis Equipment and Supplies Market Size, Share, Growth, and Industry Analysis, By Type (Gel Electrophoresis (GE),Capillary Electrophoresis (CE),Electrophoresis Accessories), By Application (Proteins (Diagnostics),Microbial Detection,Hemoglobin), Regional Insights and Forecast to 2035

Electrophoresis Equipment and Supplies Market Overview

The global Electrophoresis Equipment and Supplies Market size is projected to grow from USD 1978.65 million in 2026 to USD 2053.84 million in 2027, reaching USD 2767.62 million by 2035, expanding at a CAGR of 3.8% during the forecast period.

The electrophoresis equipment and supplies market encompasses a wide range of products such as gel electrophoresis systems, capillary electrophoresis systems, electrophoresis reagents, and accessories used primarily for separating macromolecules based on their size and charge. Globally, over 15 million electrophoresis tests are performed annually in research laboratories and clinical settings. The market has witnessed the deployment of more than 200,000 electrophoresis units worldwide, driven by increasing applications in genomics, proteomics, and molecular biology research. The demand for high-throughput electrophoresis equipment has increased by 35% over the past five years, reflecting the surge in biotechnology research. Electrophoresis equipment and supplies market report data indicates growing investments in automated and miniaturized electrophoresis systems to enhance laboratory efficiency.

The USA holds a significant share in the electrophoresis equipment and supplies market, accounting for approximately 30% of the global consumption of electrophoresis equipment. More than 60,000 electrophoresis units are operational across academic, pharmaceutical, and diagnostic laboratories in the country. Federal funding for biomedical research in the USA exceeded $50 billion in 2024, directly fueling electrophoresis equipment procurement and supply chains. The US market for electrophoresis supplies reports a steady increase in demand for advanced capillary electrophoresis and gel electrophoresis systems, with around 45% of US-based laboratories adopting next-generation electrophoresis technologies for DNA and protein analysis. Additionally, the US healthcare sector contributes to nearly 40% of the electrophoresis reagents consumption nationally.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 55% of market growth is attributed to increased investments in pharmaceutical and biotechnology research sectors.
• Major Market Restraint: Around 30% of laboratories report budget constraints limiting new equipment purchases.
• Emerging Trends: 40% of new market entrants focus on integrating electrophoresis with digital imaging and data analytics.
• Regional Leadership: North America leads with a 35% market share, followed by Europe at 28%.
• Competitive Landscape: Top five companies control over 65% of the electrophoresis equipment and supplies market.
• Market Segmentation: Gel electrophoresis accounts for 50% of equipment demand; capillary electrophoresis holds 35%.
• Recent Development: 38% of manufacturers have launched automated electrophoresis systems between 2023 and 2025.

Electrophoresis Equipment and Supplies Market Latest Trends

Recent trends in the electrophoresis equipment and supplies market highlight the growing preference for automated and high-throughput electrophoresis systems. Approximately 42% of laboratories globally have transitioned from manual gel electrophoresis systems to automated platforms within the last three years. The surge in proteomics and genomics research has increased the adoption of capillary electrophoresis equipment by 37%. Researchers are prioritizing electrophoresis devices that offer enhanced resolution and faster run times, reflected in a 28% rise in sales of high-voltage electrophoresis units. Additionally, the integration of electrophoresis with advanced imaging software has grown by 34%, enabling more accurate data analysis and interpretation. Sustainability is emerging as a key trend; around 20% of electrophoresis equipment manufacturers have introduced eco-friendly supplies, including reusable gels and reduced chemical usage. The rise in biopharmaceuticals has driven demand for electrophoresis supplies in quality control processes, accounting for 25% of total consumables usage in 2024. Furthermore, the COVID-19 pandemic accelerated the adoption of remote and automated electrophoresis monitoring systems, with a 30% increase in telemetric device implementation in clinical laboratories. These latest trends indicate a market focused on efficiency, automation, and sustainability.

Electrophoresis Equipment and Supplies Market Dynamics

DRIVER

"Rising demand for pharmaceuticals and biotechnology research"

The demand for electrophoresis equipment and supplies is primarily driven by the expanding pharmaceutical sector, which accounts for nearly 50% of market consumption. In 2024, over 12,000 pharmaceutical companies worldwide employed electrophoresis techniques for drug discovery and quality control. The increase in genetic research projects, now exceeding 7,500 globally, has further elevated the demand for DNA and protein electrophoresis supplies. Additionally, advancements in personalized medicine and biomarker discovery are fueling equipment upgrades in more than 60% of research institutions, contributing to the market’s robust growth.

RESTRAINT

"High costs of electrophoresis equipment and supplies"

One of the main restraints in the electrophoresis equipment and supplies market is the high initial cost of sophisticated electrophoresis systems, particularly automated and capillary electrophoresis devices, which can exceed $50,000 per unit. Budget limitations in smaller research facilities and academic institutions restrict the replacement rate of outdated equipment, with 30% of labs continuing to use older manual systems due to cost constraints. Moreover, the recurring expense of proprietary reagents and consumables, which account for 40% of total operational costs in laboratories, dampens market expansion, especially in developing economies.

OPPORTUNITY

"Growing applications in personalized medicine and diagnostics"

Emerging opportunities in personalized medicine and molecular diagnostics are expected to drive market expansion. Over 5,000 clinical laboratories worldwide adopted electrophoresis equipment for disease biomarker detection in 2024, representing a 25% increase from previous years. The rising prevalence of genetic disorders and cancer diagnostics has opened avenues for electrophoresis in clinical applications. Furthermore, the integration of electrophoresis with next-generation sequencing (NGS) technologies is creating new market opportunities, with over 1,200 laboratories combining these platforms to improve accuracy in genomic analysis. These applications account for a 33% rise in demand for electrophoresis consumables.

CHALLENGE

"Stringent regulatory compliance and quality standards"

The electrophoresis equipment and supplies market faces significant challenges from stringent regulatory frameworks, especially in Europe and North America, where 65% of equipment must comply with ISO and FDA standards. Achieving compliance often delays product launches by up to 12 months and increases manufacturing costs by 15%. Additionally, supply chain disruptions and raw material shortages have affected 40% of manufacturers, leading to delays in equipment deliveries. These challenges necessitate higher investments in quality assurance and supply chain management, posing hurdles for new market entrants.

Electrophoresis Equipment and Supplies Market Segmentation

The electrophoresis equipment and supplies market is segmented by type and application to cater to diverse research and diagnostic needs. By type, the market is divided into proteins (diagnostics), microbial detection, and hemoglobin analysis. Proteins diagnostics account for 45% of total equipment usage globally, with over 8 million tests conducted annually using electrophoresis techniques. Microbial detection applications constitute 30%, primarily in clinical microbiology labs performing approximately 4.5 million tests yearly. Hemoglobin analysis makes up 25% of the market, with more than 3 million diagnostic tests performed annually, particularly for anemia and hemoglobinopathies. By application, the segmentation includes gel electrophoresis (GE), capillary electrophoresis (CE), and electrophoresis accessories. Gel electrophoresis leads the market, comprising 50% of total demand with over 100,000 systems in use worldwide. Capillary electrophoresis accounts for 35%, favored for its higher resolution and speed, with approximately 70,000 units installed in genomics and pharmaceutical labs. Accessories, including power supplies, gels, and buffers, make up the remaining 15%, representing annual consumable sales exceeding 10 million units globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Proteins (Diagnostics): Protein electrophoresis diagnostics are utilized in over 8 million tests annually worldwide, primarily for disease marker identification and immune disorder diagnosis. The demand for protein electrophoresis equipment surged by 30% in clinical laboratories between 2021 and 2024, largely driven by its application in detecting multiple myeloma and chronic inflammatory conditions. Advanced protein electrophoresis devices, capable of separating complex protein mixtures within two hours, now dominate approximately 40% of installed units globally. The US and Europe account for nearly 60% of protein electrophoresis market share due to their robust healthcare infrastructure and high testing volume.

The proteins (diagnostics) segment is anticipated to reach a market size of approximately USD 710 million by 2025, holding a significant market share and growing at a CAGR of 4.1% during the forecast period.

Top 5 Major Dominant Countries in the Proteins (Diagnostics) Segment

• United States: With a market size of USD 260 million, the U.S. dominates the segment, holding a 36.6% share and growing at a CAGR of 4.3%.
• Germany: Germany follows with USD 105 million market size, 14.8% share, and a CAGR of 3.9%.
• Japan: Japan commands USD 95 million, representing 13.4% share and a CAGR of 3.7%.
• China: China’s market size is USD 90 million, with a 12.7% share and a CAGR of 4.2%.
• United Kingdom: The UK holds USD 60 million in market size, 8.5% share, and a CAGR of 3.6%.

Microbial Detection: Microbial detection through electrophoresis has grown steadily, with more than 4.5 million microbial identification tests conducted annually using electrophoretic techniques. This segment is crucial for antibiotic resistance screening and pathogen characterization in clinical microbiology labs. Microbial detection electrophoresis equipment sales rose by 25% in emerging economies between 2022 and 2024, with Asia-Pacific laboratories increasing adoption due to rising infectious disease burden. Portable and user-friendly electrophoresis systems represent 35% of sales in this segment, supporting point-of-care diagnostics.

Microbial detection electrophoresis equipment is estimated to have a market size of USD 720 million in 2025, accounting for a substantial share and expanding at a CAGR of 3.6% through 2034.

Top 5 Major Dominant Countries in the Microbial Detection Segment

• United States: USD 250 million market size, 34.7% share, CAGR of 3.8%.
• Germany: USD 110 million, 15.3% share, CAGR of 3.4%.
• Japan: USD 100 million, 13.9% share, CAGR of 3.5%.
• China: USD 95 million, 13.2% share, CAGR of 3.9%.
• France: USD 55 million, 7.6% share, CAGR of 3.3%.

Hemoglobin: Hemoglobin electrophoresis accounts for 25% of the total electrophoresis market, with over 3 million diagnostic tests performed globally each year. This segment is essential for diagnosing hemoglobinopathies such as sickle cell anemia and thalassemia. Hemoglobin electrophoresis devices designed for rapid results constitute 30% of installed equipment worldwide, with significant use in pediatric and hematology clinics. North America and Europe together contribute 55% of global hemoglobin electrophoresis equipment sales due to well-established newborn screening programs.

The hemoglobin segment is expected to reach USD 475 million in market size by 2025, with a notable market share and a CAGR of 3.2% during the forecast timeframe.

Top 5 Major Dominant Countries in the Hemoglobin Segment

• United States: USD 170 million, 35.8% market share, CAGR of 3.4%.
• China: USD 80 million, 16.8% share, CAGR of 3.3%.
• Japan: USD 70 million, 14.7% share, CAGR of 3.1%.
• Germany: USD 65 million, 13.7% share, CAGR of 3.0%.
• Canada: USD 40 million, 8.4% share, CAGR of 3.2%.

BY APPLICATION

Gel Electrophoresis (GE): Gel electrophoresis remains the most widely used electrophoresis application, representing 50% of total equipment demand. Over 100,000 gel electrophoresis systems are operational worldwide, used extensively for DNA, RNA, and protein separation. The technique accounts for 65% of electrophoresis reagent consumption globally, with agarose gels making up 45% of gels used. Sales of precast gels increased by 20% in the last three years as labs seek time-saving solutions. Educational and research institutions contribute to 40% of global gel electrophoresis equipment demand.

Gel electrophoresis holds a dominant market position, valued at USD 920 million in 2025, with a market share reflecting steady growth at a CAGR of 3.7%.

Top 5 Major Dominant Countries in the Gel Electrophoresis Application

• United States: USD 320 million market size, 34.8% share, CAGR of 3.9%.
• Germany: USD 120 million, 13.0% share, CAGR of 3.5%.
• China: USD 110 million, 12.0% share, CAGR of 4.0%.
• Japan: USD 105 million, 11.4% share, CAGR of 3.6%.
• United Kingdom: USD 80 million, 8.7% share, CAGR of 3.4%.

Capillary Electrophoresis (CE): Capillary electrophoresis accounts for 35% of electrophoresis equipment market demand, favored for high sensitivity and automation capabilities. Approximately 70,000 CE systems are installed worldwide, primarily in pharmaceutical quality control and genomic research laboratories. Between 2022 and 2024, CE consumable usage increased by 28%, driven by growing applications in protein characterization and DNA fragment analysis. European markets represent 40% of capillary electrophoresis system sales due to stringent quality control requirements in drug development.

Capillary electrophoresis is expected to reach USD 710 million by 2025, showing promising expansion at a CAGR of 4.0%, driven by advanced applications in diagnostics and research.

Top 5 Major Dominant Countries in the Capillary Electrophoresis Application

• United States: USD 270 million, 38.0% market share, CAGR of 4.2%.
• Japan: USD 110 million, 15.4% share, CAGR of 3.9%.
• Germany: USD 95 million, 13.4% share, CAGR of 3.8%.
• China: USD 90 million, 12.7% share, CAGR of 4.1%.
• France: USD 60 million, 8.4% share, CAGR of 3.6%.

Electrophoresis Accessories: Electrophoresis accessories, including power supplies, gels, buffers, and imaging systems, represent 15% of the market demand. Over 10 million electrophoresis consumable units are sold annually, with buffers and reagents accounting for 50% of accessory sales volume. Technological advances have led to the adoption of real-time imaging and data capture accessories in 35% of research laboratories. Accessories markets in North America and Asia-Pacific collectively account for 65% of global sales, driven by growing laboratory automation trends.

The electrophoresis accessories segment is projected to reach USD 275 million by 2025, expanding steadily at a CAGR of 3.3% due to rising consumable and replacement demand.

Top 5 Major Dominant Countries in the Electrophoresis Accessories Application

• United States: USD 100 million, 36.4% share, CAGR of 3.5%.
• Germany: USD 45 million, 16.4% share, CAGR of 3.2%.
• Japan: USD 40 million, 14.5% share, CAGR of 3.1%.
• China: USD 35 million, 12.7% share, CAGR of 3.4%.
• United Kingdom: USD 30 million, 10.9% share, CAGR of 3.0%.

Electrophoresis Equipment and Supplies Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America leads the electrophoresis equipment and supplies market with a market share of roughly 35%, driven predominantly by the United States. In 2024, over 60,000 electrophoresis units were in active use in the region, supported by extensive federal and private research funding. The US accounts for 85% of North America’s electrophoresis consumables usage, with more than 20 million electrophoresis tests conducted annually across pharmaceutical, clinical, and academic labs. The adoption rate of automated electrophoresis systems in North America stands at 48%, significantly higher than the global average of 38%. The region also leads in capillary electrophoresis equipment, holding 40% of global installed CE units. Investments in biopharmaceutical research and diagnostic laboratories continue to sustain North America’s leadership.

The North American market is valued at USD 750 million in 2025, holding a strong share globally and growing at a CAGR of 3.9%, driven primarily by technological advancements and healthcare investments.

North America - Major Dominant Countries in the Electrophoresis Equipment and Supplies Market

• United States: USD 620 million market size, 82.7% share, CAGR of 4.0%.
• Canada: USD 80 million, 10.7% share, CAGR of 3.7%.
• Mexico: USD 25 million, 3.3% share, CAGR of 3.4%.
• Puerto Rico: USD 15 million, 2.0% share, CAGR of 3.3%.
• Cuba: USD 10 million, 1.3% share, CAGR of 3.1%.

EUROPE

Europe holds approximately 28% of the global electrophoresis equipment and supplies market, with Germany, the UK, and France as major contributors. The region hosts over 50,000 electrophoresis units, with gel electrophoresis systems accounting for 55% of installed devices. European laboratories perform more than 15 million electrophoresis tests annually, focusing largely on clinical diagnostics and proteomics research. Regulatory stringency in Europe has driven the development of advanced electrophoresis systems compliant with CE and ISO standards, with 60% of new equipment designed to meet these regulations. The region’s pharmaceutical sector contributes to 40% of total electrophoresis reagent consumption, reflecting high utilization in drug development and quality control.

Europe’s electrophoresis market is estimated at USD 600 million in 2025, with a market share of about 31.5% and a CAGR of 3.5%, supported by research funding and diagnostic demand.

Europe - Major Dominant Countries in the Electrophoresis Equipment and Supplies Market

• Germany: USD 180 million market size, 30.0% share, CAGR of 3.6%.
• United Kingdom: USD 110 million, 18.3% share, CAGR of 3.3%.
• France: USD 95 million, 15.8% share, CAGR of 3.4%.
• Italy: USD 75 million, 12.5% share, CAGR of 3.1%.
• Spain: USD 50 million, 8.3% share, CAGR of 3.2%.

ASIA-PACIFIC

Asia-Pacific has expanded rapidly in the electrophoresis equipment and supplies market, holding an estimated 25% market share. The region boasts over 45,000 electrophoresis units, with China, Japan, and India leading adoption. The volume of electrophoresis tests in Asia-Pacific laboratories reached approximately 10 million in 2024, a 30% increase from 2021. The rise of biotechnology firms and government-funded research programs in this region has increased demand for cost-effective electrophoresis supplies, with gel electrophoresis accounting for 60% of equipment sales. The capillary electrophoresis segment is gaining traction, with a 25% rise in installations attributed to pharmaceutical companies. Additionally, Asia-Pacific's consumable sales represent 20% of the global electrophoresis reagents market.

Asia’s market is projected at USD 420 million in 2025, with increasing adoption in emerging countries and a CAGR of 4.1%, driven by expanding healthcare infrastructure.

Asia - Major Dominant Countries in the Electrophoresis Equipment and Supplies Market

• China: USD 160 million market size, 38.1% share, CAGR of 4.3%.
• Japan: USD 110 million, 26.2% share, CAGR of 3.8%.
• India: USD 70 million, 16.7% share, CAGR of 4.5%.
• South Korea: USD 40 million, 9.5% share, CAGR of 3.6%.
• Australia: USD 30 million, 7.1% share, CAGR of 3.4%.

MIDDLE EAST & AFRICA

The Middle East & Africa market accounts for about 7% of the global electrophoresis equipment and supplies market. Growing healthcare infrastructure projects and increasing investments in molecular diagnostics have contributed to a 15% rise in electrophoresis equipment installations over the last three years. Approximately 10,000 electrophoresis units are currently in operation across the region, with gel electrophoresis representing 70% of demand. The region conducts around 1.5 million electrophoresis tests annually, mainly in clinical laboratories focused on infectious diseases and genetic disorders. The market is supported by government initiatives promoting advanced diagnostic techniques, with consumable sales rising steadily.

The Middle East and Africa region holds a market size of USD 130 million in 2025 with steady growth at a CAGR of 3.3%, fueled by rising healthcare investments and diagnostic advancements.

Middle East and Africa - Major Dominant Countries in the Electrophoresis Equipment and Supplies Market

• Saudi Arabia: USD 45 million market size, 34.6% share, CAGR of 3.4%.
• South Africa: USD 35 million, 26.9% share, CAGR of 3.2%.
• United Arab Emirates: USD 25 million, 19.2% share, CAGR of 3.5%.
• Egypt: USD 15 million, 11.5% share, CAGR of 3.1%.
• Nigeria: USD 10 million, 7.7% share, CAGR of 3.0%.

List of Top Electrophoresis Equipment and Supplies Market Companies

• Agilent Technologies
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• General Electric Company
• Hoefer Inc.
• Beckman Coulter Inc.
• Lonza Group Ltd.
• SERVA Electrophoresis GmbH
• B.S Scientific Company Inc.
• SEBIA
• Helena Laboratories Corporation

Top Two Companies with Highest Market Share

• Thermo Fisher Scientific Inc.: Holds approximately 22% of the global electrophoresis equipment and supplies market, with over 50,000 units sold worldwide. The company leads in automated gel and capillary electrophoresis technologies, supplying more than 35 million electrophoresis consumables annually.
• Bio-Rad Laboratories Inc.: Commands about 18% market share, with a product portfolio that includes over 40,000 installed electrophoresis systems globally. Bio-Rad provides electrophoresis reagents for more than 10 million tests per year and has a strong presence in clinical and research sectors.

Investment Analysis and Opportunities

Investments in electrophoresis equipment and supplies have intensified, with global research expenditures on molecular biology surpassing $100 billion annually in 2024. Approximately 60% of this funding is directed towards laboratory equipment upgrades, including electrophoresis systems. Private equity and venture capital firms have increased their investments by 35% in startups focused on electrophoresis automation and miniaturization technologies. Emerging markets such as China, India, and Brazil present significant investment opportunities, with annual growth in equipment sales exceeding 25% in these regions. The rising demand for personalized medicine and biomarker discovery in cancer diagnostics is attracting pharmaceutical companies to invest heavily in capillary electrophoresis and electrophoresis accessories. Over 5,000 new electrophoresis systems were procured globally by biopharma companies in 2024. Additionally, government grants totaling $15 billion worldwide in 2024 support research laboratories upgrading to high-throughput electrophoresis equipment. These investments are creating lucrative opportunities for manufacturers to expand product portfolios and market reach, particularly in consumables and software integration.

New Product Development

Innovation in electrophoresis equipment and supplies has accelerated, with over 40 new product launches globally between 2023 and 2025. Major manufacturers are focusing on automated gel electrophoresis systems capable of processing up to 96 samples simultaneously, improving throughput by 50%. Developments in microfluidic electrophoresis chips have allowed a 30% reduction in sample volumes required for analysis, enhancing efficiency in clinical diagnostics. The introduction of hybrid electrophoresis systems combining capillary and gel technologies has grown by 20%, providing greater versatility in biomolecule separation. New electrophoresis reagents with enhanced stability and reduced toxicity have increased lab safety compliance by 25%. Real-time data capture and cloud-based analytics integration are now standard in 35% of newly launched electrophoresis systems, offering improved workflow and data management. These innovations are driving the electrophoresis equipment and supplies market towards automation, miniaturization, and user-friendly operation.

Five Recent Developments

• Launch of a fully automated gel electrophoresis system capable of processing 96 samples per run, increasing throughput by 50%.
• Introduction of a portable capillary electrophoresis device with a 30% reduction in sample volume requirement, enhancing point-of-care testing.
• Development of eco-friendly electrophoresis gels that reduce chemical waste by 40%, adopted by 20% of laboratories globally.
• Integration of cloud-based electrophoresis data analysis software in 35% of new devices, facilitating remote access and collaboration.
• Expansion of electrophoresis consumable manufacturing capacity by 25% to meet rising global demand, especially in emerging markets.

Report Coverage of Electrophoresis Equipment and Supplies Market

The electrophoresis equipment and supplies market report provides a comprehensive overview of market size, segmentation, competitive landscape, and regional analysis. It covers more than 20 key product types and over 15 application areas, offering detailed insights into market trends, growth drivers, and challenges. The report examines over 10 leading companies, providing market share data and recent development updates. It also includes in-depth regional analysis of North America, Europe, Asia-Pacific, and Middle East & Africa, highlighting market penetration and demand patterns. Key market metrics such as unit shipments, consumable sales volume, and test frequency statistics are analyzed to provide a holistic market outlook. The report offers strategic recommendations for manufacturers, suppliers, and investors seeking opportunities in electrophoresis equipment and supplies. Additionally, it tracks technological innovations, regulatory impacts, and evolving customer preferences to deliver actionable market insights. With detailed segmentation by type and application, the report serves as a vital tool for stakeholders engaged in the electrophoresis equipment and supplies industry.

Electrophoresis Equipment and Supplies Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1978.65 Million in 2026
Market Size Value By	USD 2767.62 Million by 2035
Growth Rate	CAGR of 3.8% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Gel Electrophoresis (GE) Capillary Electrophoresis (CE) Electrophoresis Accessories By Application : Proteins (Diagnostics) Microbial Detection Hemoglobin
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample